Progyny (PGNY) Asset Writedowns and Impairment (2018 - 2026)
Progyny's (PGNY) quarterly Asset Writedowns and Impairment came in at $5.7 million in Q2 2026, up 7.13% year-over-year from $5.4 million in Q2 2025, and up 29.4% quarter-over-quarter from $4.4 million in Q1 2026.
Analysis
Progyny (PGNY) Asset Writedowns and Impairment (2018 - 2026) Analysis & Trends
Progyny (PGNY) has reported Asset Writedowns and Impairment for 9 consecutive years, with $5.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 7.13% year-over-year to $5.7 million in Q2 2026; TTM through Jun 2026 was $19.7 million, a 10.34% increase from a year earlier, with the FY2025 full-year figure at $20.5 million, up 25.19% from the prior year.
- Asset Writedowns and Impairment was $5.7 million for Q2 2026 at Progyny, up from $4.4 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $5.7 million in Q2 2026 and troughed at $2.3 million in Q1 2022.
- A 5-year average of $4.5 million and a median of $4.7 million in 2023 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment soared 129.9% in 2023 and slumped 39.98% in 2024, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at $4.1 million in 2022, then grew by 18.57% to $4.9 million in 2023, then decreased by 24.84% to $3.7 million in 2024, then jumped by 41.48% to $5.2 million in 2025, then advanced by 10.79% to $5.7 million in 2026.
- The last three Asset Writedowns and Impairment figures came in at $5.7 million (Q2 2026), $4.4 million (Q1 2026), and $5.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.74 Mn |
| Mar 31, 2026 | 4.44 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Sep 30, 2025 | 4.33 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Jun 30, 2024 | 4.80 Mn |
| Mar 31, 2024 | 4.77 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 4.11 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 3.82 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 2.42 Mn |